Kahn J P
Service de Psychologie Médicale et Psychothérapie, CHU de Nancy, Hôpital Jeanne d'Arc, Dommartin-les-Toul.
Encephale. 1996 Jun;22 Spec No 2:49-54.
Neuroleptics have been held responsible for cognitive impairments and negative symptoms in the course of schizophrenia. On the other hand, recent data suggest that alterations in information processing, cognitive and neuro-psychological functions are present at early stages in the developmental course of the illness. Two recent reviews, by D. King and G. Cassens suggest that, although acute administration of neuroleptics may alter performances in some neuro-psychological functions, there is no convincing evidence so far, to support a significant role of chronic neuroleptic treatment in the development of negative symptoms and cognitive dysfunction in schizophrenia. Despite several methodological limitations, which preclude any definitive statement, experimental and clinical data suggest that chronic neuroleptic treatment might improve neuropsychological functioning and the deficit syndrome, in some groups of schizophrenic patients. These results are examined in the framework of recent theoretical developments, which emphasize the role of cognitive dysfunction in the pathophysiology of schizophrenia.
抗精神病药物一直被认为与精神分裂症病程中的认知障碍和阴性症状有关。另一方面,最近的数据表明,在该疾病发展过程的早期阶段就存在信息处理、认知和神经心理功能的改变。D. 金和G. 卡森斯最近的两篇综述表明,尽管急性使用抗精神病药物可能会改变某些神经心理功能的表现,但迄今为止,尚无令人信服的证据支持长期使用抗精神病药物治疗在精神分裂症阴性症状和认知功能障碍发展中起重要作用。尽管存在一些方法学上的局限性,这些局限性排除了任何确定性的结论,但实验和临床数据表明,长期使用抗精神病药物治疗可能会改善某些精神分裂症患者群体的神经心理功能和缺陷综合征。这些结果在最近理论发展的框架内进行了审视,这些理论发展强调了认知功能障碍在精神分裂症病理生理学中的作用。